Thermo Fisher Scientific (TMO) Gross Profit (2009 - 2026)

Thermo Fisher Scientific has disclosed Gross Profit across 18 years of filings, most recently posting $7.7 billion for Q1 2026.

• Quarterly Gross Profit rose 6.98% year-over-year to $7.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.2 billion (up 6.93% YoY) and the FY2025 annual result came in at $31.6 billion, up 4.69% from the prior year.
• Gross Profit slipped to $7.7 billion in Q1 2026, from $9.0 billion in the prior quarter.
• Over five years, Gross Profit peaked at $9.0 billion in Q4 2025 and troughed at $7.1 billion in Q1 2024.
• A 5-year average of $7.7 billion and a median of $7.5 billion in 2023 frame the typical range for Gross Profit.
• Biggest YoY gain for Gross Profit was 25.89% in 2022; the steepest drop was 47.16% in 2022.
• Tracing TMO's Gross Profit over 5 years: stood at $7.8 billion in 2022, then slipped by 7.92% to $7.2 billion in 2023, then advanced by 10.86% to $7.9 billion in 2024, then grew by 13.3% to $9.0 billion in 2025, then declined by 13.81% to $7.7 billion in 2026.
• Business Quant data shows TMO's Gross Profit at $7.7 billion in Q1 2026, $9.0 billion in Q4 2025, and $7.8 billion in Q3 2025.